Cerus Aims For Intercept Plasma PMA Approval By 2014 For Pathogen Inactivation
This article was originally published in The Gray Sheet
Executive Summary
The first component of a modular PMA submission is slated for the first quarter of 2013. If approved, the device would be the first pathogen inactivation system available in the U.S. for donated blood components.